Cohere acquires Reliant AI to launch sovereign biopharma platform.
Article excerpt
Highlighted: the sentence this signal was extracted from
Cohere acquires Reliant AI to launch sovereign biopharma platform. Published. June 18, 2026 Enterprise AI provider Cohere has recently announced the acquisition of Reliant AI, a Montreal- and Berlin-based specialist in biopharma data analytics. The transaction integrates Reliant AI's research team, specialized biomedical datasets, and domain-optimized technology into Cohere's enterprise platform. As part of the transaction, Cohere will assume Reliant AI's existing customer relationships, which include pharmaceutical companies such as GSK, Medicus Pharma, and Kyowa Kirin. Financial terms of the deal were not disclosed. Cohere will use the acquired capabilities to accelerate the development of "North for Pharma," an upcoming agentic AI system designed to automate administrative, clinical, and research workflows within the highly regulated life sciences sector. Reliant AI's core product functions as an intelligent research workbench that automates systematic literature reviews, competitive landscaping, and data extraction to model market viability and accelerate drug development timelines. The acquisition allows Cohere to expand its portfolio of jurisdiction-specific "sovereign AI" offerings, building on its structural footprints in Canada and Germany where data privacy boundaries are strictly regulated. The transition brings Reliant AI's leadership directly into Cohere's...
Keep reading with a free account
The rest of this article, and every signal for Cohere, is in your free account.
